Literature DB >> 3986905

Transmembrane orientation of glycoproteins encoded by the v-fms oncogene.

C W Rettenmier, M F Roussel, C O Quinn, G R Kitchingman, A T Look, C J Sherr.   

Abstract

The retroviral oncogene v-fms encodes a glycoprotein whose transport to the plasma membrane is required for transformation. Tryptic digestion of microsomes from transformed cells yielded membrane-protected amino-terminal fragments 40 kd smaller than intact molecules. These fragments were glycosylated, and they included v-fms-coded epitopes expressed at the cell surface. Deletion of the predicted membrane-spanning peptide generated polypeptides that were completely sequestered within microsomes. The mutant glycoproteins acquired more asparagine-linked oligosaccharide chains than did wild-type molecules, lacked kinase activity in vitro, were not transported to the cell surface, and had no transforming activity. Thus, the membrane-spanning segment in the middle of the glycoprotein interrupts translocation of nascent chains into the endoplasmic reticulum, ultimately orienting the amino-terminal domain outside the cell and the carboxy-terminal kinase domain in the cytoplasm. These topological features are similar to those of several growth factor receptors, suggesting that v-fms transforms cells through modified receptor-mediated signals.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3986905     DOI: 10.1016/0092-8674(85)90357-5

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  24 in total

1.  Differential transcription of exon 1 of the human c-fms gene in placental trophoblasts and monocytes.

Authors:  J Visvader; I M Verma
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

2.  Analysis of functional domains of the v-fms-encoded protein of Susan McDonough strain feline sarcoma virus by linker insertion mutagenesis.

Authors:  S D Lyman; L R Rohrschneider
Journal:  Mol Cell Biol       Date:  1987-09       Impact factor: 4.272

3.  The putative transforming protein of S13 avian erythroblastosis virus is a transmembrane glycoprotein with an associated protein kinase activity.

Authors:  M J Hayman; G Kitchener; P K Vogt; H Beug
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

4.  Tyrosine phosphorylations in vivo associated with v-fms transformation.

Authors:  D K Morrison; P J Browning; M F White; T M Roberts
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

5.  The amino-terminal domain of the v-fms oncogene product includes a functional signal peptide that directs synthesis of a transforming glycoprotein in the absence of feline leukemia virus gag sequences.

Authors:  E F Wheeler; M F Roussel; A Hampe; M H Walker; V A Fried; A T Look; C W Rettenmier; C J Sherr
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

6.  "Replacement" of COOH-terminal truncation of v-fms with c-fms sequences markedly reduces transformation potential.

Authors:  P J Browning; H F Bunn; A Cline; M Shuman; A W Nienhuis
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

7.  Transforming activity of retroviral genomes encoding Gag-Axl fusion proteins.

Authors:  Q K Zhang; S Boast; K de los Santos; M Begemann; S P Goff
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

8.  The v-fms oncogene induces factor-independent growth and transformation of the interleukin-3-dependent myeloid cell line FDC-P1.

Authors:  E F Wheeler; D Askew; S May; J N Ihle; C J Sherr
Journal:  Mol Cell Biol       Date:  1987-05       Impact factor: 4.272

9.  A new acute transforming feline retrovirus with fms homology specifies a C-terminally truncated version of the c-fms protein that is different from SM-feline sarcoma virus v-fms protein.

Authors:  P Besmer; E Lader; P C George; P J Bergold; F H Qiu; E E Zuckerman; W D Hardy
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

10.  Differential processing of colony-stimulating factor 1 precursors encoded by two human cDNAs.

Authors:  C W Rettenmier; M F Roussel
Journal:  Mol Cell Biol       Date:  1988-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.